DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis

Nat Genet. 2006 Nov;38(11):1248-50. doi: 10.1038/ng1868. Epub 2006 Oct 8.

Abstract

Hypophosphatemia is a genetically heterogeneous disease. Here, we mapped an autosomal recessive form (designated ARHP) to chromosome 4q21 and identified homozygous mutations in DMP1 (dentin matrix protein 1), which encodes a non-collagenous bone matrix protein expressed in osteoblasts and osteocytes. Intact plasma levels of the phosphaturic protein FGF23 were clearly elevated in two of four affected individuals, providing a possible explanation for the phosphaturia and inappropriately normal 1,25(OH)2D levels and suggesting that DMP1 may regulate FGF23 expression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Bone Matrix / metabolism*
  • Child
  • Extracellular Matrix Proteins / genetics*
  • Extracellular Matrix Proteins / metabolism
  • Extracellular Matrix Proteins / physiology
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / genetics
  • Fibroblast Growth Factors / metabolism
  • Homeostasis
  • Humans
  • Hypophosphatemia / genetics*
  • Infant
  • Mutation
  • PHEX Phosphate Regulating Neutral Endopeptidase / genetics
  • PHEX Phosphate Regulating Neutral Endopeptidase / metabolism
  • Pedigree
  • Phosphates / metabolism*
  • Phosphoproteins / genetics*
  • Phosphoproteins / metabolism
  • Phosphoproteins / physiology

Substances

  • DMP1 protein, human
  • Extracellular Matrix Proteins
  • FGF23 protein, human
  • Phosphates
  • Phosphoproteins
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • PHEX Phosphate Regulating Neutral Endopeptidase
  • PHEX protein, human